Definitive Healthcare Corp. Hits New 52-Week Low at $1.37

Definitive Healthcare Corp., a microcap player in the Software Products industry, has reached a new 52-week low of USD 1.37 on February 23, 2026. This significant decline marks a stark contrast to its 52-week high of USD 5.23, reflecting a challenging year for the company with a staggering 76.41% drop in its stock price over the past year. The company's market capitalization stands at USD 214 million, and it currently exhibits a price-to-earnings (P/E) ratio of 6.00, indicating a low valuation relative to its earnings. However, the firm has not paid any dividends, and its debt-to-equity ratio is slightly negative at -0.06. The return on equity (ROE) is reported at 6.08%, suggesting limited profitability in generating returns for shareholders. In comparison to the S&P 500, which has gained 12.95% over the same period, Definitive Healthcare's performance has been notably poor, with consistent underperformance over the last three years. The stock's recent activity underscores the ongoing challenges faced by the company in a competitive market landscape.